5-METHYL-1-(2,3,5-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-1H-IMIDAZO-[4,5-B]-PYRIDIN-6-AMINE
Compound with spectra: 1 NMR
![5-METHYL-1-(2,3,5-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-1H-IMIDAZO-[4,5-B]-PYRIDIN-6-AMINE](/api/compound/Dt1p6TGcOZH.png?ph=true&h=300&w=458 "5-METHYL-1-(2,3,5-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-1H-IMIDAZO-[4,5-B]-PYRIDIN-6-AMINE")
| SpectraBase Compound ID | Dt1p6TGcOZH |
|---|---|
| InChI | InChI=1S/C18H22N4O7/c1-8-12(19)5-13-17(21-8)20-7-22(13)18-16(28-11(4)25)15(27-10(3)24)14(29-18)6-26-9(2)23/h5,7,14-16,18H,6,19H2,1-4H3/t14-,15-,16-,18-/m1/s1 |
| InChIKey | MYBVXFAMVJHESC-YFHUEUNASA-N |
| Mol Weight | 406.4 g/mol |
| Molecular Formula | C18H22N4O7 |
| Exact Mass | 406.148849 g/mol |
| Enantiomer InChIKey | MYBVXFAMVJHESC-OVWQWFNUSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
4,6-DICHLORO-9-(2,3,5-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-3-DEAZA-PURINE
5-METHYL-3-(2,3,5-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-3H-IMIDAZO-[4,5-B]-PYRIDINE
[1-(15)-N]-6-BROMO-9-(2',3',5'-TRI-O-ACETYL-BETA-D-RIBOFURANOSYL)-9H-PURINE
ALPHA-ADENOSINE-2',3',5'-TRIACETATE
ADENOSINE-TRIACETATE
(2R,3R,4R,5R)-2-(acetoxymethyl)-5-(6-amino-9H-purin-9-yl)tetrahydrofuran-3,4-diyl diacetate
9H-Purine, 2-(methylthio)-9-(2,3,5-tri-O-acetyl-.beta.-D-ribofuranosyl)-
1-(2,3,5-Tri-O-acetyl-.beta.-D-ribofuranosyl)indole-3-carboxaldehyde
2',3'-DI-O-ACETYL-5-DEOXY-5-(FLUOROMETHYLTHIO)ADENOSINE
2',3'-DI-O-ACETYL-5'-S-(FLUOROMETHYL)-5'-THIOADENOSINE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of New Nebularine Analogues and Their Inhibitory Activity against Adenosine Deaminase | CHEMICAL & PHARMACEUTICAL BULLETIN | 2015 |